Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type
- PMID: 22609237
- PMCID: PMC3535474
- DOI: 10.1016/j.ajic.2012.01.012
Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type
Abstract
Background: Major postoperative infections (MPIs) are poorly understood complications of cardiac surgery. We examined the epidemiology, microbiology, and outcome of MPIs occurring after cardiac surgery.
Methods: The study cohort was drawn from the Society of Thoracic Surgeon National Cardiac Database and comprised adults who underwent cardiac surgery at 5 tertiary hospitals between 2000 and 2004. We studied the incidence, microbiology, and risk factors of MPI (bloodstream or chest wound infections within 30 days after surgery), as well as 30-day mortality. We used multivariate regression analyses to evaluate the risk of MPI and mortality.
Results: MPI was identified in 341 of 10,522 patients (3.2%). Staphylococci were found in 52.5% of these patients, gram-negative bacilli (GNB) in 24.3%, and other pathogens in 23.2%. High body mass index, previous coronary bypass surgery, emergency surgery, renal impairment, immunosuppression, cardiac failure, and peripheral/cerebrovascular disease were associated with the development of MPI. Median postoperative duration of hospitalization (15 days vs 6 days) and mortality (8.5% vs 2.2%) were higher in patients with MPIs. Compared with uninfected individuals, odds of mortality were higher in patients with S aureus MPIs (adjusted odds ratio, 3.7) and GNB MPIs (adjusted odds ratio, 3.0).
Conclusions: Staphylococci accounted for the majority of MPIs after cardiac surgery. Mortality was higher in patients with Staphylococcus aureus- and GNB-related MPIs than in patients with MPIs caused by other pathogens and uninfected patients. Preventive strategies should target likely pathogens and high-risk patients undergoing cardiac surgery.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.
Conflict of interest statement
Conflict of interest: L.F.C. has received research support from Merck & Co and is a speaker for Cubist Pharmaceuticals. J.M.A. is an employee and shareholder of Merck & Co. L.H.M. has received research support from Merck & Co. V.G.F. was supported in part by grant K24 AI093969 and has received research support from the National Institutes of Health, Astellas, Pfizer, Novartis, MedImmune, Advanced Liquid Logic, Cubist, Merck & Co, Theravance, Inhibitex, and Cerexa. The other authors have no conflicts of interest to disclose.
References
-
- Harrington G, Russo P, Spelman D, Borrell S, Watson K, Barr W, et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol. 2004;25:472–6. - PubMed
-
- Fowler VG, Jr, O’Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 2005;112(9 Suppl):I358–65. - PubMed
-
- Eklund AM, Lyytikäinen O, Klemets P, Huotari K, Anttila VJ, Werkkala KA, et al. Mediastinitis after more than 10,000 cardiac surgical procedures. Ann Thorac Surg. 2006;82:1784–9. - PubMed
-
- Lucet JC Parisian Mediastinitis Study Group. Surgical site infection after cardiac surgery: a simplified surveillance method. Infect Control Hosp Epidemiol. 2006;27:1393–6. - PubMed
-
- Coskun D, Aytac J, Aydinli A, Bayer A. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect. 2005;60:176–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
